Harmony Biosciences

Harmony Biosciences is an innovative biopharmaceutical company dedicated to identifying, developing, and commercializing novel treatment options for patients with rare diseases. With an emphasis on Central Nervous System (CNS) disorders, Harmony partnered with Bioprojet SCR to develop, register and market the drug, pitolisant, for the potential treatment of adult narcolepsy. Pitolisant, a histamine H3- receptor antagonist/inverse agonist, is approved by European Medicines Agency under the brand name Wakix.